| |
|
|
|
 |
|
 |
|
 |
| |
|
VUEMED and The Optime Group commissioned a survey in July 2011 to evaluate physicians’ perspectives on their
relationships with supply chain/materials organizations, their contribution to the product selection/purchasing
decisions, and the impact of healthcare reform on their practice.
The findings will be presented as part of the CMO panel discussion at IDN Summit: Achieving Supply Chain Success
Download physician survey results
|
| * * * |
Read VUEMED's presentation on how our superior VueTrack technology solves the problem of the "blind spot" in hospitals.
VueTrack & The Blind Spot (PDF)
|
|
| |
| |
VUEMED,
Inc
2621 East Ward St, Seattle, WA 98112
Phone: 1-888-948-0999
E-mail: info@vuemed.com |
| |
|
|
| |
A clinical
inventory control tool that puts you
in control.
VueTrack by VUEMED is a powerful, easy-to-use inventory management
tool that provides real-time tracking
of medical products, devices and supplies.
VueTrack empowers clinical and materials managers with complete
knowledge and control over their inventory:
Know what products are
on the shelves at all times
Track every item used
in a procedure
Set rational, usage-based
inventory par levels
Identify expiring and
recalled items instantaneously
And much more…
In short, VueTrack gives you the power to fully and
efficiently control
your inventory, improve
patient care,
increase
staff productivity, and cut
costs.
VueTrack can be set up over a weekend so that you’re
up and running with no interruptions. Your technologists
and nurses will like its simplicity, and you will love to
know everything you need to know about your inventory
at any time. Best of all, VueTrack pays for itself almost
immediately, with a return on investment (ROI) of over 400%.
All at the most
competitive pricing in the industry - guaranteed.
VueTrack integrates four intuitive and easy-to-use functions
to monitor and analyze all your clinical inventory
transactions in real-time. Click on the tabs below to learn about these powerful S.T.A.R. functions:
SCAN
TRACK
ANALYZE
REPORT
|
| |
|